Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Invested Capital (2024 - 2026)

Indivior Pharmaceuticals has reported Return on Invested Capital over the past 3 years, most recently at 0.03% for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 3.0% year-over-year to 0.03%; the TTM value through Mar 2026 reached 0.03%, down 3.0%, while the annual FY2025 figure was 0.06%, 6.0% down from the prior year.
  • Return on Invested Capital for Q1 2026 was 0.03% at Indivior Pharmaceuticals, down from 0.02% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.01% in Q2 2024 and troughed at 0.03% in Q1 2026.
  • A 3-year average of 0.01% and a median of 0.0% in 2024 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2025 and later fell -3bps in 2026.
  • Year by year, Return on Invested Capital stood at 0.0% in 2024, then crashed by -2759bps to 0.02% in 2025, then plummeted by -49bps to 0.03% in 2026.
  • Business Quant data shows Return on Invested Capital for INDV at 0.03% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.